Cloning and characterization of glial cell line-derived neurotrophic factor receptor-B: A novel receptor for members of glial cell line-derived neurotrophic factor family of neurotrophic factors

Neuroscience ◽  
1998 ◽  
Vol 83 (1) ◽  
pp. 7-14 ◽  
Author(s):  
C.-Y. Wang ◽  
J. Ni ◽  
H. Jiang ◽  
T.-A. Hsu ◽  
M. Dugich-Djordjevic ◽  
...  
Oncogene ◽  
2000 ◽  
Vol 19 (39) ◽  
pp. 4469-4475 ◽  
Author(s):  
Hironori Hayashi ◽  
Masatoshi Ichihara ◽  
Toshihide Iwashita ◽  
Hideki Murakami ◽  
Yohei Shimono ◽  
...  

2021 ◽  
Vol 9 (A) ◽  
pp. 1006-1010
Author(s):  
Agus Roy Rusly Hariantana Hamid ◽  
Sri Maliawan ◽  
DPG Purwa Samatra ◽  
I Nyoman Mantik Astawa ◽  
I Made Bakta ◽  
...  

BACKGROUND: The role of neurotrophic factors (brain-derived neurotrophic factors and glial cell line-derived neurotrophic factors) and early electrical stimulation (EES) in the injured nerve has found promising in several studies. However, there is still limited knowledge about the effect of EES in the distal part of the nerve to sustain this level of expression of growth factors. AIM: We aim to evaluate the effects of EES in in neural regeneration by measuring the expression of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in animal model. METHODS: The research was conducted starting from April to May 2021 using male Wistar rats. Using general anesthesia, the sciatic nerve was cut. The intervention group was treated with EES in the distal stump, right after nerve resection (20 Hz, 1–2 mA, 2–5 s), while the control group received no treatment after nerve resection. A reoperation on day 3 was performed in both groups to measure BDNF and GDNF expression level of the distal nerve tissue by ELISA as well as histopathological examination of sprouting axons of the injured proximal nerve. RESULTS: A total of 32 samples were included in the study. A statistically significant levels of GDNF is found higher in the EES group (n = 16) than the control group (n = 16) (35. 71 pg/100 mg, confidence interval (CI) 95% 23.93, 47.48, p < 0.05). The number of sprouting axons is found lower in the EES group (p < 0.05). The BDNF level is similar between the two groups, however not significant. After a subgroup analysis, it was found that the greater the level of GDNF, the fewer the axon sprouts in both groups (fewer axon group 58.35 [n = 22, CI 95% 45.14, 71.55] vs. more axon group 47.14 [n = 10, CI 95% 35.33, 58.95]), p < 0.05. CONCLUSION: The EES proves its benefit in accelerating the axonal regeneration by increasing the expression GDNF in the distal nerve stumps in the electrical excited degenerated sciatic nerve in the rat model.


2005 ◽  
Vol 95 (2) ◽  
pp. 537-543 ◽  
Author(s):  
Asako Hase ◽  
Fumiaki Saito ◽  
Hiroki Yamada ◽  
Ken Arai ◽  
Teruo Shimizu ◽  
...  

2020 ◽  
Vol 382 (1) ◽  
pp. 173-183 ◽  
Author(s):  
Pia Runeberg-Roos ◽  
Richard D Penn

Abstract The last decade has been a frustrating time for investigators who had envisioned major advances in the treatment of Parkinson’s disease using neurotrophic factors. The first trials of glial cell line–derived neurotrophic factor for treating Parkinson’s disease were very promising. Later blinded control trials were disappointing, not reaching the predetermined outcomes for improvement in motor function. Consideration of the problems in the studies as well as the biology of the neurotrophins used can potentially lead to more effective therapies. Parkinson’s disease presents a multitude of opportunities for the cell biologist wanting to understand its pathology and to find possible new avenues for treatment.


2002 ◽  
Vol 70 (4) ◽  
pp. 1383-1393 ◽  
Author(s):  
Ren Y. Xu ◽  
Kevin Pong ◽  
Yanbin Yu ◽  
David Chang ◽  
Shuying Liu ◽  
...  

2010 ◽  
Vol 30 (34) ◽  
pp. 11403-11413 ◽  
Author(s):  
L. Lonka-Nevalaita ◽  
M. Lume ◽  
S. Leppanen ◽  
E. Jokitalo ◽  
J. Peranen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document